Study explores links between antidiabetic meds, multiple sclerosis risk


For patients with type 2 diabetes (T2D), exposure to antihyperglycemic medications (A-HgMs) is associated with a decreased risk for developing multiple sclerosis (MS) in those who are younger than 45 years and an increased risk for developing MS in those who are older than 45 years, according to a study published online Oct. 21 in Heliyon.

Guillermo del Toro’s ‘Pinocchio’ trailer is absolutely gorgeous and should win every Oscar ever for animation

Previous article

‘Click chemistry’ can deliver drugs to treat bone tumors in dogs

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations